Cohance's Suryapet plant shut after fatal accident order

Cohance Lifesciences Limited received a 5 November 2026 order requiring the immediate suspension of manufacturing at its Suryapet, Telangana site after an industrial accident led to one employee’s death. The Telangana State Pollution Control Board identified alleged safety-measure non-compliances under applicable consent conditions, while Cohance said the financial and operational effects cannot yet be quantified.

What did TGPCB order Cohance to do at Suryapet?

The Telangana State Pollution Control Board, or TGPCB, ordered Cohance to suspend manufacturing activities at the Suryapet site with immediate effect. Cohance received the closure direction on 5 November 2026 and disclosed it to the National Stock Exchange of India and BSE Limited in a filing dated 6 November 2026.

The disclosed restriction is a closure order, not a monetary penalty. In Form A, Cohance identified the sanction as a “Closure Order” and listed its period of applicability as “Immediate”, requiring manufacturing to stop rather than continue pending a later implementation date.

The 5 November 2026 order date and 6 November 2026 exchange-disclosure date cover different events: the first marks TGPCB’s action and the second Cohance’s public notification. The filing does not state a fixed duration for the closure beyond its immediate application.

What accident led to the Suryapet closure order?

The closure followed an industrial accident during manufacturing that exposed one employee on duty at the Suryapet facility. Cohance said the employee received emergency medical assistance immediately and was shifted to a specialised hospital in Hyderabad for advanced treatment.

The employee subsequently died from the injuries despite treatment and efforts by the medical teams, according to the 6 November 2026 filing. Cohance did not disclose the accident date, the manufacturing process involved, the substance involved, or the equipment associated with the exposure.

TGPCB inspected the facility after the accident and the employee’s eventual death, then identified certain alleged non-compliances with applicable consent conditions. That inspection resulted in the order to halt manufacturing at Suryapet immediately.

The disclosed sequence is limited but clear: an accident occurred during manufacturing, one employee was exposed and later died, TGPCB inspected the site, and the authority imposed the closure order. Cohance did not state that TGPCB had made a final legal finding of liability, describing the issues as alleged non-compliances.

Which safety issues did TGPCB identify at Cohance?

TGPCB identified alleged non-compliances in implementing safety measures required under applicable consent conditions. Form A describes the issue as a lack of strict implementation of accident-prevention safety measures in line with those consent conditions.

The filing does not list specific equipment failures, safety systems, operating procedures or individual consent-condition clauses. It also does not disclose an environmental release, remediation order, prosecution, fine or separate sanction beyond the immediate closure of Suryapet manufacturing.

Cohance made the disclosure under Regulation 30 of the Securities and Exchange Board of India, or SEBI, Listing Obligations and Disclosure Requirements Regulations, 2015. The filing also refers to Clause 20 of Schedule III and the SEBI Master Circular dated 30 January 2026 as the reporting framework.

What is Cohance doing to seek the Suryapet reopening?

Cohance said it has immediately started corrective and preventive measures addressing the observations in TGPCB’s directions. The company expects to submit representations and compliances promptly to seek cancellation of the closure directions and permission to resume Suryapet operations.

The filing refers to submitting those materials to “TBPCB”, although the authority named throughout the disclosure and Form A is TGPCB. Cohance did not explain the difference, provide a planned submission date, or set a target date for restarting manufacturing.

The company’s stated response is linked directly to the alleged lack of strict implementation of accident-prevention safety measures. However, Cohance did not specify which measures have been completed, what actions remain, or whether TGPCB must reinspect the Suryapet facility before reopening.

As of the 6 November 2026 disclosure, Cohance had not reported a regulator response, a reopening approval or a revised production schedule. It said it would keep the stock exchanges informed of material developments.

What financial and operational impact has Cohance disclosed?

Cohance said it is assessing the operational and financial impact of the Suryapet closure and cannot quantify the effect with reasonable certainty at this stage. The filing provides no revenue, profit, production-volume, customer, inventory, employee-count or order-book figure for the affected site.

The absence of a quantified effect means the immediate disclosed consequence is operational: Suryapet manufacturing must stop. Cohance did not state whether output can move to another facility, whether supply commitments are affected, or whether fixed costs continue during the closure.

The filing contains no comparison of Suryapet output with other Cohance sites or business segments. It also gives no comparison with a prior accident, closure, inspection or consent-condition case, leaving the 5 November 2026 order and the 6 November 2026 filing as the only disclosed event-date comparison.

Any estimate of lost sales, margin effects, insurance recovery, restart costs, regulatory liability or closure duration would go beyond Cohance’s disclosure. The company’s stated position is that both the operating and financial implications remain under assessment.

Conclusion

Cohance has disclosed an immediate TGPCB closure order for its Suryapet manufacturing site following a fatal industrial accident involving one employee and alleged safety-condition non-compliances. The filing establishes the operating restriction and the regulator’s stated basis, but does not quantify the shutdown’s financial cost or identify a reopening date.

The next disclosed step is Cohance’s planned submission of representations and compliances seeking cancellation of the closure directions and resumption of operations. The matters to watch are TGPCB’s response, details of corrective and preventive measures, any reopening decision, and Cohance’s eventual assessment of financial and operational effects.